Castrejon, Isabel http://orcid.org/0000-0003-1811-2417
Shakoor, Najia
Chua, Jacquelin R. http://orcid.org/0000-0003-0831-3346
Block, Joel A.
Article History
Received: 23 August 2018
Accepted: 25 September 2018
First Online: 6 October 2018
Compliance with ethical standards
:
: IC declares that she has no conflict of interest. NS declares that she has no conflict of interest. JRC declares that she has no conflict of interest. JAB is a Board of Directors Member of the American College of Rheumatology and the Osteoarthritis Research Society International and has received consulting fees from Zynerba Pharma and Glaxo SmithKline.
: This study was conducted in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. The study was reviewed and approved by the Institutional Review Board at Rush University Medical Center and it received an IRB waiver of patient consent for retrospective use of data up to February 28, 2017 (Rush Rheumatic Diseases Patient Reported Outcomes Studies: 14090502-IRB02-AM03).